Variability of treatment duration for bacteraemia in the critically ill: A multinational survey.
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: No definitive evidence is available to inform 'best' antibiotic practice for treating bacteraemia in the critically ill patient, either in terms of duration of therapy, or the use of mono- versus combination therapy. We therefore undertook a large-scale international survey to assess the variability of current practice. METHODS: A questionnaire was sent to membership lists of national and international intensive care societies. RESULTS: Responses from 254 intensive care units in 34 countries revealed a wide variation in antibiotic strategy for all types of bacteraemia, ranging from short course ( or=10 days) use of broad-spectrum combinations. Two factors were significantly associated with antibiotic prescribing practice, namely the country of origin (in those with >or=10 responders) and the level of microbiologist and/or infectious diseases specialist input. The greater the specialist input, the shorter the duration of therapy (P < 0.0001). CONCLUSIONS: The wide variability in antibiotic prescribing patterns suggests an urgent need to produce high-quality evidence to identify optimal antibiotic prescribing policies for bacteraemia in the critically ill patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While there appears to be no overall effect of neuraminidase inhibitors on mortality in patients with influenza-related pneumonia, there may be an effect when administered early in the course of the disease (225).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [225]
In the citing paper
“Given the lack of definitive and generalizable data regarding the optimal duration of therapy for patients who are critically ill, it is not surprising that there is considerably practice variation [281, 294].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [294]
Citations
Cites
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
A 25-year study of nosocomial bacteremia in an adult intensive care unit
Edgeworth, J. D., Treacher, D. F., & Eykyn, S. J. (1999) · Critical Care Medicine · doi:10.1097/00003246-199908000-00002 · Cited by 178
Early and late onset bacteremia have different risk factors in trauma patients
Antonelli, M. M., Moro, M. L., D’Errico, R. R., Conti, G., Bufi, M., & GASPARETTO, A. (1996) · Intensive Care Medicine · doi:10.1007/bf01709514 · Cited by 27
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis
Havey, T. C., Fowler, R. A., & Daneman, N. (2011) · Critical Care · doi:10.1186/cc10545 · Cited by 187
“In the absence of high-grade evidence, there is wide variability in antibiotic treatment duration recommendations from infectious disease and critical care specialists, and the presence of bacteremia is often used as a justification for extended courses of antibiotic therapy regardless of the observed clinical respons…”
BackgroundChotiprasitsakul, D., Han, J. H., Cosgrove, S. E., Harris, A. D., Lautenbach, E., Conley, A. T., Tolomeo, P., Wise, J., Tamma, P. D., & Antibacterial Resistance Leadership Group (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix767 · Cited by 173
“A 2001 multinational survey revealed that the durations of antibiotic therapy prescribed for gram-negative bacteremia range widely among clinicians [13].”
BackgroundEliakim-Raz, N., Yahav, D., Paul, M., & Leibovici, L. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt177 · Cited by 153
Cepeda, J. A., Whitehouse, T., Cooper, B., Hails, J., Jones, K., Kwaku, F., Taylor, L., Hayman, S., Shaw, S., Kibbler, C., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh048 · Cited by 114
Corona, A., Bertolini, G., Lipman, J., Wilson, A. P., & Singer, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq088 · Cited by 90
Self-citationKao, L. S., Fleming, G. M., Escamilla, R. J., Lew, D. F., & Lally, K. P. (2011) · ASAIO Journal · doi:10.1097/mat.0b013e31820d19ab · Cited by 87
The missing care bundle: antibiotic prescribing in hospitals
Cooke, F. J., & Holmes, A. H. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.03.003 · Cited by 81
Póvoa, P. M. S. R., Coelho, L., Almeida, E., Fernandes, A., Mealha, R., Moreira, P., & Sabino, H. A. C. (2005) · Clinical Infectious Diseases · doi:10.1086/430382 · Cited by 71
“agnosis of BSI, in particular systemic inflammatory response syndrome criteria [8].”
BackgroundAntimicrobial Treatment Duration in Sepsis and Serious Infections
Busch, L. M., & Kadri, S. S. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa247 · Cited by 63
“As such, it is not surprising that usual care durations of antibiotic therapy for sepsis and serious infections remain highly variable [27].”
BackgroundEnd-of-Life Treatment and Bacterial Antibiotic Resistance
Levin, P. D., Simor, A. E., Moses, A. E., & Sprung, C. L. (2010) · CHEST Journal · doi:10.1378/chest.09-2757 · Cited by 57
Daneman, N., Shore, K., Pinto, R. L., & Fowler, R. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.07.016 · Cited by 57
Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study
Malacarne, P., Rossi, C., & Bertolini, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh299 · Cited by 52
Short antibiotic treatment courses or how short is short?
Rubinstein, E. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.017 · Cited by 47
Short- versus long-course therapy in gram-negative bacilli bloodstream infections
Sousa, A., Pérez-Rodríguez, M. T., Suárez, M., Val, N., Martínez-Lamas, L., Nodar, A., Longueira, R., & Casal, M. C. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03467-5 · Cited by 45
Havey, T., Fowler, R., Pinto, R. L., Elligsen, M., & Daneman, N. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/141989 · Cited by 40
Park, S. H., Milstone, A. M., Diener‐West, M., Nussenblatt, V. R., Cosgrove, S. E., & Tamma, P. D. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt424 · Cited by 38
Corona, A., Santis, V. D., Agarossi, A., Prete, A., Cattaneo, D., Tomasini, G., Bonetti, G., Patroni, A., & Latronico, N. (2023) · Antibiotics · doi:10.3390/antibiotics12081262 · Cited by 42
Self-citationEpidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia
Ong, D. S. Y., Bonten, M. J. M., Safdari, K., Spitoni, C., Frencken, J. F., Witteveen, E., Horn, J., Klouwenberg, P. M. C. K., & Cremer, O. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ560 · Cited by 37
“ICU-acquired bacteremia [4, 5].”
Corona, A., Wilson, A. P. R., Grassi, M., & Singer, M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh416 · Cited by 35
“As no ICU-specific randomized trials exist, individual ICUs have evolved different strategies, using short (4–7 days) or long (10–14 days plus) courses of either mono- or combination antibiotic therapy.(14) The latter offers broad spectrum and often synergic cover, whereas short-course monotherapy reduces both antibio…”
BackgroundSelf-citationSantis, V. D., Gresoiu, M., Corona, A., Wilson, A. P. R., & Singer, M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku338 · Cited by 32
Self-citationVenkatesh, B., Kennedy, P., Krüger, P., Looke, D. F. M., Jones, M., Hall, J., & Ray‐Barruel, G. (2009) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0903700102 · Cited by 18
“Median SoFA score (range) 6 (0-14) 6 (1-13) 0.”
Ranganath, N., Yetmar, Z. A., McCandless, A., Rivera, C. G., Lahr, B. D., Tande, A. J., & Shah, A. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14085 · Cited by 17
“Total duration of antimicrobial therapy 206 8 (7-10) 14 (13-14) 16 (15-18) ≤.”
Shortening the course of antibiotic treatment in the intensive care unit
Barrett, J., Edgeworth, J., & Wyncoll, D. L. A. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1008451 · Cited by 22
“For example, in one multinational survey treatment duration for bacteremia in critically ill patients varied from less than 5 days to greater than 10 days [10].”
BackgroundHojat, L. S., Bessesen, M. T., Huang, M., Reid, M., Knepper, B. C., Miller, M. A., Shihadeh, K. C., Fugit, R. V., & Jenkins, T. C. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1197 · Cited by 13
Lee, C., Hsieh, C., Yang, C.-Y., Hong, M., Lee, C.-H., Tang, H.-J., & Ko, W. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.05.014 · Cited by 12
Chan, J. D., Bryson‐Cahn, C., Kassamali‐Escobar, Z., Lynch, J. B., & Schleyer, A. M. (2020) · Journal of Hospital Medicine · doi:10.12788/jhm.3414 · Cited by 8
Any Role for Biomarker-Guide Algorithms in Antibiotic Stewardship Programs?*
Póvoa, P. M. S. R., & Kalil, A. C. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004295 · Cited by 7
“cerning the duration of antibiotic therapy (4) and that shorter”
BackgroundSwamy, S., & Sharma, R. (2015) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000362 · Cited by 6
“The catheter-related bloodstream infection guidelines suggest a 7- to 14-day course of therapy for Gram-negative bacteremia.(12) However, these recommendations are largely consensus based and have poor evidence.”
BackgroundInfluentialANTIBIOTIC USAGE IN INTENSIVE CARE UNITS OF TABRIZ IMAM REZA HOSPITAL, 2011
Taghizadeh (2013) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2013.130.135 · Cited by 6
“In another, which was conducted to evaluate, the reasons contributing in antibiotic choice and the reasons of empirical antimicrobial therapy in ICU, the results revealed the “recommendations” as an important factor (Corona et al., 2003).”
ResultEdgeworth, J., Ster, I. C., Wyncoll, D. L. A., Shankar‐Hari, M., & McKenzie, C. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku038 · Cited by 6
Top Questions in Uncomplicated, Non–Staphylococcus aureus Bacteremia
Sutton, J. D., Sayood, S. J., & Spivak, E. S. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy087 · Cited by 6
Antibiotic resistance in the ICU
Edgeworth, J. D. (2016) · doi:10.1093/med/9780199600830.003.0289 · Cited by 6
Tingsgård, S., Israelsen, S. B., Thorlacius-Ussing, L., Kirk, K. F., Lindegaard, B., Johansen, I. S., Knudsen, A., Lunding, S., Ravn, P., Andersen, C. Ø., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068606 · Cited by 4
Sutton, J. D., Lee, J. H., Howard, K., Quartuccio, K. S., McCoy, C. P., Gupta, A. K., Slish, J. C., Engers, D. W., Malani, A. N., Karaba, S. M., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf298 · Cited by 3
“Variables were selected for inclusion in the models based on prior studies [11–16] and their clinical relevance as judged by the study team.”
Rational or rationalized choices in fluid resuscitation?
Han, J. E., & Martin, G. S. (2010) · Critical Care · doi:10.1186/cc9305 · Cited by 3
“For example, in antibiotic prescription for bacteremia, the country of origin and infectious diseases specialist input were explanatory factors [18].”
BackgroundDuration of antibiotic therapy: with or without biomarkers?
Guerreiro, G., Fustiga, J., & Póvoa, P. M. S. R. (2026) · Acute and Critical Care · doi:10.4266/acc.002525 · Cited by 1
“…performed in 254 intensive care units (ICUs) revealed a wide range of non-evidence-based strategies for managing bloodstream infections (BSIs), from short-course (≤5 days) treatments with narrow-spectrum antibiotics to long-course (≥10 days) therapies involving broad-spectrum combinations [3].”
Corona, A., & Iaco, M. D. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000115 · Cited by 1
“A large questionnaire survey (4) on 254 ICUs showed 1) a wide variation in the percentage of ICUs using long courses (> 10 d) of antibiotics, for primary bacteremia (3.”
BackgroundSelf-citationThe long and short of the risk of antibiotic treatment failure
Watson, A. (2004) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2004.00653.x · Cited by 2
Duration of Antibiotic Therapy for Bacteremia in the Critically Ill: A Mythologic Chimera?
Corona, A., Ruffini, C., & Rota, L. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001797 · Cited by 1
Self-citationNew Hospital Initiatives in Fighting Resistance
Cooke, F. J., & Holmes, A. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-70841-6_7 · Cited by 1
Fiori, C., Piana, A., Manfredi, M., & Amparore, D. (2026) · Springer eBooks · doi:10.1007/978-3-031-52619-0_7
Metadata
- Authors
- Corona, A.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Corresponding author
- Corona, A.
- ORCID
- Corona, A.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09-30
- Volume
- 52
- Issue
- 5
- Pages
- 849-852
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2107284057
- Semantic Scholar
- c71bbf7070eac513daa94bfeed961940b49cd5e4
- Cited by
- 43
- References
- 3
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 3 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 4
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- Gilead Sciences
- Intensive Care Society
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- bacteremia, critically ill patients, antibiotic duration, antibiotic prescribing, combination antibiotic therapy, broad-spectrum antibiotics, intensive care unit, international variation in practice
- MeSH terms
- Anti-Bacterial Agents, Drug Therapy, Combination, Humans, Intensive Care Units, Surveys and Questionnaires, Societies, Medical, Time Factors, Bacteremia, Critical Illness, Health Care Surveys, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.